Edwards Lifesciences Corporation (EW)
NYSE: EW · Real-Time Price · USD
82.61
-1.66 (-1.97%)
At close: Mar 18, 2026, 4:00 PM EDT
82.07
-0.54 (-0.65%)
After-hours: Mar 18, 2026, 7:06 PM EDT

Edwards Lifesciences Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
47,98049,50543,57445,83445,38580,852
Market Cap Growth
14.32%13.61%-4.93%0.99%-43.87%41.96%
Enterprise Value
44,45245,95940,33944,93344,83680,050
Last Close Price
82.6185.2574.0376.2574.61129.55
PE Ratio
45.6446.5810.6233.1530.5854.43
Forward PE
27.9430.9331.1928.4130.3552.98
PEG Ratio
2.163.243.692.772.953.38
PS Ratio
7.918.168.019.1510.1715.45
PB Ratio
4.644.794.366.897.8213.85
P/TBV Ratio
4.684.834.446.998.0214.01
P/FCF Ratio
35.9437.08150.3171.3046.6257.49
P/OCF Ratio
30.0831.0380.3551.1737.2646.68
EV/Sales Ratio
7.337.577.428.9710.0415.30
EV/EBITDA Ratio
24.7732.3526.3030.9127.3743.86
EV/EBIT Ratio
27.1436.3529.2634.3329.9247.36
EV/FCF Ratio
33.3034.43139.1569.9046.0556.92
Debt / Equity Ratio
0.070.070.070.100.110.11
Debt / EBITDA Ratio
0.500.500.460.470.420.38
Debt / FCF Ratio
0.530.532.421.070.710.49
Net Debt / Equity Ratio
-0.34-0.34-0.33-0.14-0.09-0.13
Net Debt / EBITDA Ratio
-2.48-2.48-2.14-0.65-0.32-0.42
Net Debt / FCF Ratio
-2.64-2.64-11.30-1.47-0.54-0.55
Asset Turnover
0.450.450.490.570.530.66
Inventory Turnover
1.211.211.121.100.901.63
Quick Ratio
2.832.833.122.061.872.07
Current Ratio
3.723.724.183.383.033.08
Return on Equity (ROE)
20.90%20.90%66.58%41.82%48.89%28.88%
Return on Assets (ROA)
7.84%7.84%11.09%13.18%15.55%18.97%
Return on Invested Capital (ROIC)
13.73%13.73%17.40%18.23%21.56%27.15%
Return on Capital Employed (ROCE)
10.79%10.79%13.98%16.96%20.33%24.47%
Earnings Yield
2.24%2.15%9.42%3.02%3.27%1.84%
FCF Yield
2.78%2.70%0.67%1.40%2.15%1.74%
Buyback Yield / Dilution
1.50%1.45%2.25%1.55%3.48%0.44%
Updated Dec 31, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q